The Anti-Tumor Efficacy of 3C23K, a Glyco-Engineered Humanized Anti-Misrii Antibody, in an Ovarian Cancer Model Is Mainly Mediated by Engagement of Immune Effector Cells

Oncotarget - United States
doi 10.18632/oncotarget.15715

Related search